Home > Compound List > Product Information
7-Fluoro-4-hydroxycoumarin_Molecular_structure_CAS_2145-27-9)
Click picture or here to close

7-Fluoro-4-hydroxycoumarin

Catalog No. 732982 Name Sigma Aldrich
CAS Number 2145-27-9 Website http://www.sigmaaldrich.com
M. F. C9H5FO3 Telephone 1-800-521-8956
M. W. 180.1326032 Fax
Purity Email
Storage Chembase ID: 143627

SYNONYMS

IUPAC name
7-fluoro-4-hydroxy-2H-chromen-2-one
IUPAC Traditional name
7-fluoro-4-hydroxychromen-2-one
Synonyms
7-Fluoro-4-hydroxy-2H-chromen-2-one
7-Fluoro-4-hydroxy-1(2H)-benzopyran-2-one

DATABASE IDS

MDL Number MFCD11845381
CAS Number 2145-27-9

PROPERTIES

Empirical Formula (Hill Notation) C9H5FO3
Melting Point 220-225 °C
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H302
European Hazard Symbols Harmful Harmful (Xn)
MSDS Link Download
Risk Statements 22
German water hazard class 3

DETAILS

Description (English)
Packaging
250 mg in glass bottle
Application
Reactant for:
• Enantioselective synthesis of polycyclic coumarins via in situ formed primary amine-imine-catalyzed asymmetric Michael addition to cyclic enones1
• Preparation of dicoumarol analogs as inhibitors of human NAD(P)H quinone oxidoreductase-1 (NQO1) as agents active against human pancreatic and colon cancer cells2
• Imidazolidinecarboxylic acid-catalyzed asymmetric Michael reaction with unsaturated ketones in a highly atom-economic catalytic one-step formation of optically active warfarin anticoagulant3
• Asymmetric synthesis of functionalized α-keto esters and their hemiketal and hemiaminal derivatives via direct Michael addition with unsaturated α-keto esters catalyzed by bisoxazoline-copper(II) complexes4
Description (简体中文)
包装
250 mg in glass bottle
Application
Reactant for:
• Enantioselective synthesis of polycyclic coumarins via in situ formed primary amine-imine-catalyzed asymmetric Michael addition to cyclic enones1
• Preparation of dicoumarol analogs as inhibitors of human NAD(P)H quinone oxidoreductase-1 (NQO1) as agents active against human pancreatic and colon cancer cells2
• Imidazolidinecarboxylic acid-catalyzed asymmetric Michael reaction with unsaturated ketones in a highly atom-economic catalytic one-step formation of optically active warfarin anticoagulant3
• Asymmetric synthesis of functionalized α-keto esters and their hemiketal and hemiaminal derivatives via direct Michael addition with unsaturated α-keto esters catalyzed by bisoxazoline-copper(II) complexes4

REFERENCES